← Back

$ Value

$0

Shares

152,718

Price

$0

Filed

Jan 16

Insider

Name

Chapman Steven Leonard

Title

CEO AND PRESIDENT

CIK

0001711968

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-14

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

289,286

Footnotes

On January 27, 2023, the Reporting Person was granted a performance-based Restricted Stock Unit (RSU) award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 14, 2026, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 152,718 shares of Common Stock.

Filing Info

Accession No.

0001711968-26-000003

Form Type

4

Issuer CIK

0001604821

Chapman Steven Leonard's History

Date Ticker Type Value
2026-03-10 NTRA $1.1M
2026-03-09 NTRA A
2026-03-02 NTRA $223K
2026-03-02 NTRA $493K
2026-03-02 NTRA $73K
2026-02-27 NTRA A
2026-02-03 NTRA $1.1M
2026-02-02 NTRA $1.5M
2026-02-02 NTRA $9.6M
2026-02-02 NTRA $4.6M

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10